Trials / Completed
CompletedNCT02970019
Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease
A Double-blind, Placebo-controlled Study to Determine Safety, Tolerability, Pharmacokinetic of K0706.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K0706 | Once a day administration after fast |
| DRUG | Placebo | Once a day administration after fast |
Timeline
- Start date
- 2017-03-30
- Primary completion
- 2019-05-28
- Completion
- 2019-05-28
- First posted
- 2016-11-21
- Last updated
- 2020-03-31
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02970019. Inclusion in this directory is not an endorsement.